These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34060432)

  • 21. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In silico design of novel CDK2 inhibitors through QSAR, ADMET, molecular docking and molecular dynamics simulation studies.
    Moussaoui M; Baassi M; Baammi S; Soufi H; Salah M; Daoud R; El Allali A; Belghiti ME; Belaaouad S
    J Biomol Struct Dyn; 2023; 41(23):13646-13662. PubMed ID: 37203327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligand-based pharmacophore modeling of TNF-α to design novel inhibitors using virtual screening and molecular dynamics.
    Jade DD; Pandey R; Kumar R; Gupta D
    J Biomol Struct Dyn; 2022 Mar; 40(4):1702-1718. PubMed ID: 33034255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Combined Approach of Pharmacophore Modeling, QSAR Study, Molecular Docking and In silico ADME/Tox Prediction of 4-Arylthio & 4-Aryloxy-3- Iodopyridine-2(1H)-one Analogs to Identify Potential Reverse Transcriptase Inhibitor: Anti-HIV Agents.
    Panigrahi D; Mishra A; Sahu SK; Azam MA; Vyshaag CM
    Med Chem; 2022; 18(1):51-87. PubMed ID: 33319692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An insight into selective and potent inhibition of histone deacetylase 8 through induced-fit docking, pharmacophore modeling and QSAR studies.
    Kashyap K; Kakkar R
    J Biomol Struct Dyn; 2020 Jan; 38(1):48-65. PubMed ID: 30633630
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Akabli T; Toufik H; Lamchouri F
    J Biomol Struct Dyn; 2022 Jun; 40(9):3965-3978. PubMed ID: 33252029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.
    Chaudhari HK; Pahelkar A
    Infect Disord Drug Targets; 2019; 19(2):145-166. PubMed ID: 30324898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined QSAR and molecule docking studies on predicting P-glycoprotein inhibitors.
    Tan W; Mei H; Chao L; Liu T; Pan X; Shu M; Yang L
    J Comput Aided Mol Des; 2013 Dec; 27(12):1067-73. PubMed ID: 24322389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probing the binding mechanism of substituted pyridine derivatives as effective and selective lysine-specific demethylase 1 inhibitors using 3D-QSAR, molecular docking and molecular dynamics simulations.
    Wang ZZ; Yang J; Sun XD; Ma CY; Gao QB; Ding L; Liu HM
    J Biomol Struct Dyn; 2019 Aug; 37(13):3482-3495. PubMed ID: 30175693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
    Musoev A; Numonov S; You Z; Gao H
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cysteine focused covalent inhibitors against the main protease of SARS-CoV-2.
    Paul AS; Islam R; Parves MR; Mamun AA; Shahriar I; Hossain MI; Hossain MN; Ali MA; Halim MA
    J Biomol Struct Dyn; 2022 Mar; 40(4):1639-1658. PubMed ID: 33047658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking.
    Saeed M; Kadioglu O; Khalid H; Sugimoto Y; Efferth T
    J Nutr Biochem; 2015 Jan; 26(1):44-56. PubMed ID: 25459885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2D- and 3D-QSAR modelling, molecular docking and
    Shukla A; Tyagi R; Meena S; Datta D; Srivastava SK; Khan F
    J Biomol Struct Dyn; 2020 Jan; 38(1):168-185. PubMed ID: 30686140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacophore generation, atom-based 3D-QSAR and molecular dynamics simulation analyses of pyridine-3-carboxamide-6-yl-urea analogues as potential gyrase B inhibitors.
    Azam MA; Thathan J
    SAR QSAR Environ Res; 2017 Apr; 28(4):275-296. PubMed ID: 28399673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies.
    Mora Lagares L; Minovski N; Caballero Alfonso AY; Benfenati E; Wellens S; Culot M; Gosselet F; Novič M
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative structure-activity relationships analysis, homology modeling, docking and molecular dynamics studies of triterpenoid saponins as Kirsten rat sarcoma inhibitors.
    Stitou M; Toufik H; Bouachrine M; Lamchouri F
    J Biomol Struct Dyn; 2021 Jan; 39(1):152-170. PubMed ID: 31870215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico study of desmosdumotin as an anticancer agent: homology modeling, docking and molecular dynamics simulation approach.
    Gadhe CG; Kothandan G; Cho SJ
    Anticancer Agents Med Chem; 2013 Dec; 13(10):1636-44. PubMed ID: 23796247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined 3D-QSAR, molecular docking, molecular dynamics simulation, and binding free energy calculation studies on the 5-hydroxy-2H-pyridazin-3-one derivatives as HCV NS5B polymerase inhibitors.
    Yu H; Fang Y; Lu X; Liu Y; Zhang H
    Chem Biol Drug Des; 2014 Jan; 83(1):89-105. PubMed ID: 23941500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2D- and 3D-QSAR studies of a series of benzopyranes and benzopyrano[3,4b][1,4]-oxazines as inhibitors of the multidrug transporter P-glycoprotein.
    Jabeen I; Wetwitayaklung P; Chiba P; Pastor M; Ecker GF
    J Comput Aided Mol Des; 2013 Feb; 27(2):161-71. PubMed ID: 23400406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of potential
    Matos IA; Goes Pinto AC; Ferraz MVF; Adan WCS; Rodrigues RP; Dos Santos JX; Kitagawa RR; Lins RD; Oliveira TB; Costa Junior NBD
    J Biomol Struct Dyn; 2023 Jun; 41(9):3835-3846. PubMed ID: 35356863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.